In AD, given the preponderant role of APOE in developing the disease, this screening can facilitate its diagnosis by helping the identification of individuals at higher risk, thus contributing to an earlier intervention to delay AD symptoms. The gene discussed is APOE; the disease is Alzheimer disease.